Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Reinhardt

Showing results (121-130 of 236) with videos related to

Pageof 24
Sort By:
Leukemia|October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trialRobert Seifert, David Kersting, Christoph Rischpler, et al.
Cell Death & Disease|May 25, 2021
Pericentromeric Satellite III transcripts induce etoposide resistanceJulian Kanne, Michelle Hussong, Jörg Isensee, et al.
European Journal of Haematology|June 29, 2021
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvementSara Oubari, Eyad Naser, Maria Papathanasiou, et al.
Oncogene|January 12, 2018
AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancerDaniela Welcker, Manaswita Jain, Safiya Khurshid, et al.
Journal of Personalized Medicine|September 28, 2021
Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?Pia Proske, Laura Distelmaier, Carmen Aramayo-Singelmann, et al.
Hemasphere|June 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid DiseasesAlexander Carpinteiro, Christoph Kimmich, Despina Trajanova, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity TestingChristina Grimm, Axel Fischer, Angela M Farrelly, et al.
American Journal of Hematology|February 23, 2026
PTCy or ATG for Matched Transplantation in MyelofibrosisPatrizia Chiusolo, Andrea Bacigalupo, Rachel Salit, et al.
Journal of Leukocyte Biology|February 15, 2025
Risk beyond neutropenia: insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantationZülal Cibir, Alexander Beer, Andreas Kraus, et al.
Pageof 24

Showing results (121-130 of 236) with videos related to

Sort By:
Pageof 24
Leukemia|October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trialRobert Seifert, David Kersting, Christoph Rischpler, et al.
Cell Death & Disease|May 25, 2021
Pericentromeric Satellite III transcripts induce etoposide resistanceJulian Kanne, Michelle Hussong, Jörg Isensee, et al.
European Journal of Haematology|June 29, 2021
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvementSara Oubari, Eyad Naser, Maria Papathanasiou, et al.
Oncogene|January 12, 2018
AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancerDaniela Welcker, Manaswita Jain, Safiya Khurshid, et al.
Journal of Personalized Medicine|September 28, 2021
Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?Pia Proske, Laura Distelmaier, Carmen Aramayo-Singelmann, et al.
Hemasphere|June 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid DiseasesAlexander Carpinteiro, Christoph Kimmich, Despina Trajanova, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity TestingChristina Grimm, Axel Fischer, Angela M Farrelly, et al.
American Journal of Hematology|February 23, 2026
PTCy or ATG for Matched Transplantation in MyelofibrosisPatrizia Chiusolo, Andrea Bacigalupo, Rachel Salit, et al.
Journal of Leukocyte Biology|February 15, 2025
Risk beyond neutropenia: insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantationZülal Cibir, Alexander Beer, Andreas Kraus, et al.
Pageof 24